This site is intended only for healthcare professionals resident in the United Kingdom
Prescribing Information and adverse event reporting can be found at the bottom or to the right of this page
Besponsa® Pharmacy Guide
Download the Pharmacist and pharmacy staff booklet which is a guide to treatment with BESPONSA. The information provided in this document is intended to serve as a convenient reference; SmPC should be consulted for full guidance.
BESPONSA® (inotuzumab ozogamicin) 1 mg powder for concentrate for solution for infusion
Legal category: Prescription only medicine. Cost: £8,048 per vial.
Click here to access the BESPONSA Summary of Product Characteristics hosted on Datapharm’s ‘electronic Medicines Compendium’.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the SmPC for how to report adverse reactions.
Cytarabine 20 mg/mL and 100 mg/mL solution for infusion or injection
Legal category: Prescription only medicine. Basic NHS price: Cytarabine 100 mg/mL, supplied as single vials containing 100 mg/mL cytarabine in 10 mL (1 g), £39.00 or 20 mL (2 g), £77.50. Cytarabine 20 mg/mL supplied as vials containing 20 mg/mL cytarabine in 5 mL (100 mg) in packs of 5, £20.48 or 25 mL (500 mg) as single vials, £19.50. Click here to access the cytarabine 20 mg/mL and click here to access the cytarabine 100 mg/mL Summary of Product Characteristics hosted on Datapharm’s ‘electronic Medicines Compendium’.
"By clicking "confirm" to create an account, you confirm that the information you have provided above is correct, and you agree to (i) Pfizer’s processing of your personal data, including its transfer internationally and to third parties, in accordance with the Pfizer Privacy and Cookie Policy; and (ii) Pfizer’s Website Terms of Use."